Multi-country Study- Effect of Dietary Fats on Fat Deposition
Multi-country Studies on the Effect of Positional Distribution of Fatty Acids at the Triglyceride Backbone of Vegetable Oils on Fat Deposition and Selected Health Outcome Measures - Malaysia
1 other identifier
interventional
102
0 countries
N/A
Brief Summary
There is existing evidence to show that vegetable oils having unsaturated fatty acids in the sn-2 position with predominantly palmitic acid (C16:0) or stearic acid (C18:0) in the sn-1 and sn-3 positions of fat molecules do not raise serum cholesterol levels. These observations have come to be known as or explained by the "sn-2 hypothesis". New evidence have also emerged to show that saturated fatty acids (C16:0, C18:0) in the sn-1 and -3 positions reduces fat deposition in a rat model. Therefore, further studies in humans are warranted to confirm these earlier findings. Fats and oils are made up of \>90% triacylglycerol (TAG)- fat molecules which consist of a glycerol backbone to which 3 esterified fatty acids are attached. The positions of fatty acid attachment are referred to by stereospecific numbers, sn -1, -2 and -3. Early evidence shown that the unique stereospecificity of fatty acid distribution on the palm fat molecule conferred health benefits in that it inhibited experimental atherosclerosis in the rabbit model. In vegetable oils, oleic acid \[a monounsaturated fatty acid (MUFA)\] is predominantly situated at the sn-2 position, while in animals fats it is predominantly palmitic acid or stearic acid (C16:0 or C18:0-saturated fat) that is situated there. Even though palm olein and lard have similar proportions of saturated fatty acid (SFA), MUFA and polyunsatuared fatty acid (PUFA), they differ significantly in their positional distribution on the TAG molecule. Palm olein TAG contains only 7-11 % palmitic acid at the sn-2 position while about 87% is unsaturated fatty acids (oleic acid and linoleic acid). Lard has the highest amount of palmitic acid in the sn-2 position at 70%. On the other hand, in human milk, palmitic acid is predominantly in sn-2 (53-57 %) while cow milk fat contains less palmitic acid (38 %) there. It is now believed that the distribution of fatty acids in the TAG is more important than the fatty acid composition alone in conferring the oils' 'saturated' or 'unsaturated' properties. In this proposed study, the effects on the outcome measures investigated of different fatty acids (palmitic acid, oleic acid, linoleic acid) at the sn-1, sn-2 and sn-3 positions of the TAG molecule in three different test fats will be investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jan 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 2, 2016
CompletedFirst Posted
Study publicly available on registry
June 13, 2016
CompletedJune 13, 2016
June 1, 2016
5 months
June 2, 2016
June 10, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change of liver fat content
measured by magnetic resonance imaging (MRI) scan
week 0 (baseline) and week 16
Secondary Outcomes (23)
Change of body mass index (BMI)
week 0 (baseline), week 4, week 8, week 12 and week 16
Change of waist circumference
week 0 (baseline), week 4, week 8, week 12 and week 16
Change of body fat distribution/content
week 0 (baseline), week 4, week 8, week 12 and week 16
Change of visceral adiposity index (VAI)
week 0 (baseline), week 4, week 8, week 12 and week 16
Change of body adiposity index (BAI)
week 0 (baseline), week 4, week 8, week 12 and week 16
- +18 more secondary outcomes
Study Arms (3)
Test Fat Blue
EXPERIMENTAL16 weeks interventions
Test Fat Green
EXPERIMENTAL16 weeks interventions
Test Fat Red
EXPERIMENTAL16 weeks interventions
Interventions
Each subject received a palm olein-based run in diet for 2 weeks, followed by random assignment Test Fat Blue which incorporated into daily snacks (\~50g of test fats, 2 experimental cupcakes (\~15g test fat each) for breakfast and 4 pieces experimental cookies (\~5g test fat each) for afternoon tea together with a palm olein-based background diet for 16 weeks.
Each subject received a palm olein-based run in diet for 2 weeks, followed by random assignment Test Fat Green which incorporated into daily snacks (\~50g of test fats, 2 experimental cupcakes (\~15g test fat each) for breakfast and 4 pieces experimental cookies (\~5g test fat each) for afternoon tea together with a palm olein-based background diet for 16 weeks.
Each subject received a palm olein-based run in diet for 2 weeks, followed by random assignment Test Fat Red which incorporated into daily snacks (\~50g of test fats, 2 experimental cupcakes (\~15g test fat each) for breakfast and 4 pieces experimental cookies (\~5g test fat each) for afternoon tea together with a palm olein-based background diet for 16 weeks.
Eligibility Criteria
You may qualify if:
- Healthy adult male or female, aged 20-60 years
- BMI 18-5-27.5 kg/m2
You may not qualify if:
- History of any one of these chronic diseases - type 2 DM, hypertension, coronary heart disease, hyperlipidemia, liver disease, cancer
- Current problem with indigestion or constipation or bowel movement
- On medication/nutraceutiucals to reduce blood lipids or blood pressure or weight
- Pregnant or lactating women or taking COCP
- Habitual smokers (\>2 sticks per day)
- Alcoholism (\>21 units per week for men \& \>14 units per week for women)
- Mean screening blood pressure \>140/90 mmHg
- Screening TC\>6.2 mmol/L or TAG \>2.0 mmol/L
- Planned trip abroad/overseas during period of study
- Unable to adhere to at least 90% of the prescribed oil \& recommended energy and fat per day per research protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malaysia Palm Oil Boardlead
- IMU University, Malaysiacollaborator
- Universiti Putra Malaysiacollaborator
Study Officials
- STUDY CHAIR
Choo Yuen May, PhD
MPOB
- PRINCIPAL INVESTIGATOR
Augustine Ong Soon Hock, PhD
MPOB
- PRINCIPAL INVESTIGATOR
Voon Phooi Tee, PhD
MPOB
- PRINCIPAL INVESTIGATOR
Tony Ng Kock Wai, PhD
IMU
- PRINCIPAL INVESTIGATOR
Verna Lee Kar Man, PhD
IMU
- PRINCIPAL INVESTIGATOR
Norhaizan Mohd Esa, PhD
UPM
- PRINCIPAL INVESTIGATOR
Teh Soek Sin, PhD
MPOB
- PRINCIPAL INVESTIGATOR
Yap Sia Yen, PhD
MPOB
- PRINCIPAL INVESTIGATOR
Ng Yen Teng, Bsc
MPOB
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2016
First Posted
June 13, 2016
Study Start
January 1, 2016
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 13, 2016
Record last verified: 2016-06